MORRISVILLE, N.C.--(BUSINESS WIRE)--Jan. 31, 2006--Trimeris, Inc. (NASDAQ: TRMS): Trimeris, Inc. (NASDAQ: TRMS) today announced worldwide net sales of FUZEON for the year were $208.2 million, up 54 percent from $135.2 million for 2004. Net sales of FUZEON in the U.S. and Canada for the year were $112.7 million, up 32 percent from $85.7 million for 2004. Net sales of FUZEON outside the U.S. and Canada for the year were $95.5 million, up 93 percent from $49.5 million for 2004. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd., (“Roche”), Trimeris’ collaborative partner.
